Lexicon Pharmaceuticals, Inc. (LXRX)
2.325
+0.02
(+1.09%)
USD |
NASDAQ |
Aug 24, 16:00
2.325
0.00 (0.00%)
After-Hours: 20:00
Lexicon Pharmaceuticals 1 Year Total Returns (Daily) : 96.58% for Aug. 21, 2026
1 Year Total Returns (Daily) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical 1 Year Total Returns (Daily) Data
| Date | Value |
|---|---|
| August 21, 2026 | 96.58% |
| August 20, 2026 | 92.92% |
| August 19, 2026 | 107.8% |
| August 18, 2026 | 100.0% |
| August 17, 2026 | 88.71% |
| August 14, 2026 | 96.61% |
| August 13, 2026 | 110.8% |
| August 12, 2026 | 121.7% |
| August 11, 2026 | 133.7% |
| August 10, 2026 | 122.2% |
| August 07, 2026 | 120.5% |
| August 06, 2026 | 105.2% |
| August 05, 2026 | 133.3% |
| August 04, 2026 | 122.3% |
| August 03, 2026 | 117.8% |
| July 31, 2026 | 115.9% |
| July 30, 2026 | 129.4% |
| July 29, 2026 | 116.8% |
| July 28, 2026 | 114.7% |
| July 27, 2026 | 102.7% |
| July 24, 2026 | 102.7% |
| July 23, 2026 | 90.08% |
| July 22, 2026 | 87.50% |
| July 21, 2026 | 93.50% |
| July 20, 2026 | 89.43% |
| Date | Value |
|---|---|
| July 17, 2026 | 77.04% |
| July 16, 2026 | 73.64% |
| July 15, 2026 | 91.30% |
| July 14, 2026 | 79.66% |
| July 13, 2026 | 100.9% |
| July 10, 2026 | 96.46% |
| July 09, 2026 | 110.3% |
| July 08, 2026 | 147.7% |
| July 07, 2026 | 171.5% |
| July 06, 2026 | 157.5% |
| July 02, 2026 | 153.3% |
| July 01, 2026 | 164.7% |
| June 30, 2026 | 153.8% |
| June 29, 2026 | 221.6% |
| June 26, 2026 | 174.4% |
| June 25, 2026 | 154.9% |
| June 24, 2026 | 188.2% |
| June 23, 2026 | 194.2% |
| June 22, 2026 | 186.7% |
| June 18, 2026 | 169.6% |
| June 17, 2026 | 183.1% |
| June 16, 2026 | 191.0% |
| June 15, 2026 | 191.9% |
| June 12, 2026 | 175.9% |
| June 11, 2026 | 169.2% |
Total Return Definition
The Total return is the change in price over a specific period of time that includes dividends and distributions paid.
1 Year Total Returns (Daily) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
1 Year Total Returns (Daily) Benchmarks
| Viatris, Inc. | 59.76% |
| Pfizer Inc. | 16.73% |
| ANI Pharmaceuticals, Inc. | -17.32% |
| Corcept Therapeutics, Inc. | 72.23% |
| Veru, Inc. | -25.63% |